Brain-derived neuroprotective peptide therapy, widely known as Cerebrolysin, is gaining attention for its potential role in supporting recovery from neurological disorders such as stroke, traumatic brain injury (TBI), and dementia. Derived from purified neuropeptides and amino acids, this therapy is designed to mimic natural brain growth factors that help protect neurons, reduce inflammation, and promote neuroplasticity. Clinical studies suggest it may enhance cognitive function, motor recovery, and overall rehabilitation outcomes when used under medical supervision. With growing research and global clinical use, this neurorestorative approach represents a promising advancement in modern neurological care and brain recovery therapies.